Clinical Trial Update: Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris [Phase 2]

View source ↗

Summary

This update describes a Phase 2 study comparing the safety and efficacy of IDP-123 Lotion to Tazorac Cream for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• IDP-123 Lotion
• Tazorac Cream (tazarotene)

Snippet

Sponsor: Valeant Pharmaceuticals | Conditions: Acne Vulgaris | Phase 2 | Status: UNKNOWN